Renoprotection of Microcystin-RR in Unilateral Ureteral Obstruction-Induced Renal Fibrosis: Targeting the PKM2-HIF-1α Pathway
Renal fibrosis is a pathological characteristic of the endpoint of chronic kidney disease (CKD), which remains a major public health problem. None of the current therapies is effective in stopping kidney fibrosis progression. In light of our novel detection of a potential antifibrosis of microcystin...
Saved in:
Main Authors: | Yan Ren (Author), Jie Wang (Author), Wenwen Guo (Author), Jingwen Chen (Author), Xin Wu (Author), Shubo Gu (Author), Lizhi Xu (Author), Zhiwei Wu (Author), Yaping Wang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR
by: Jie Wang, et al.
Published: (2021) -
Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic Reprogramming Mediated by HIF-1α/PKM2 Positive Feedback Loop
by: Lichao Qian, et al.
Published: (2021) -
Plumbagin Protects Mice from Lethal Sepsis by Modulating Immunometabolism Upstream of PKM2
by: Zhaoxia Zhang, et al.
Published: (2016) -
PKM2-mediated neuronal hyperglycolysis enhances the risk of Parkinson's disease in diabetic rats
by: Ya Zhao, et al.
Published: (2023) -
YY1-induced upregulation of LncRNA-ARAP1-AS2 and ARAP1 promotes diabetic kidney fibrosis via aberrant glycolysis associated with EGFR/PKM2/HIF-1α pathway
by: Xin Li, et al.
Published: (2023)